Novotech is a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted ...

Shahzad Raza, MD, discusses the phase 2 RedirecTT-1 study which investigated the combination of talquetamab and teclistamab for treating patients with relapsed/refractory multiple myeloma complicated ...